ASHP-Accredited PGY2 Medication-Use Safety Residency


Pharmacy Residency

St. Jude Children’s Research Hospital offers a 12-month ASHP-Accredited Specialized Residency (PGY2) in Medication-Use Safety. 

The St. Jude Medication-Use Safety residency is a postgraduate training program that provides advanced training in medication safety.. The purpose of the program is to prepare the resident to assume a leadership role in coordinating and implementing improvements to the medication use system in a complex, high-risk patient population. St Jude is committed to providing truly comprehensive patient care. Full integration of an electronic health record that is used continuously as patients move from inpatient to ambulatory care combined with the highly skilled clinical pharmacy team provide unrivalled opportunities for direct involvement in improving medication safety across the continuum of care. The complex and high risk nature of treatment provided at St. Jude provides a unique learning environment for patient safety and quality that can be applied to any health care setting.

Throughout the program, the resident will gain experience in medication error and adverse drug event reporting and investigation processes. There will be opportunities for the resident to lead medication safety assessment and improvement efforts to prevent future patient safety events and work to maximize the patient safety benefits of the electronic health record. Other activities include newsletter writing, policy and guideline development, formulary management, and experience working with a fully integrated electronic health record. Other specific activities include participation on the Medication Use Safety Team and the Pharmacy & Therapeutics Committee in addition to patient safety activities such as root cause analyses.

Along with medication safety experiences, the resident will acquire experience in teaching through lectures, in-services, journal club presentations and precepting pharmacy students on rotation. The resident will be expected to complete a research project focused on medication safety and present the results at a national meeting. Experiences during the residency will enable the resident to seek a career focused on medication safety, medication use policy, or clinical informatics.


Rotations

After completing orientation, the resident will spend approximately 9 months of the 12-month program focusing on improving medication use practices. The resident will have the opportunity to participate in both administrative as well as patient care aspects of the St. Jude medication use process. Potential one- or two-month elective rotation experiences are available for the Medication-Use Safety resident based on individual interest. These elective learning experiences will be balanced with the longitudinal, research and other project responsibilities required within the program. Elective rotation choices for the Medication-Use Safety resident are similar to those listed for the Oncology Residency PGY2 program list, and may also include experience with a Medication Safety Officer in a large university hospital and visits to national organizations devoted to safe medication use.


Fringe benefits


Start Date

July 1


Application Deadline

January 9, 2015


Application Requirements:

All application materials must be submitted through PhORCAS.


Number of Positions

One


Program Director:

James M. Hoffman, PharmD, MS, BCPS
Medication Outcomes and Safety Officer
Associate Member, Pharmaceutical Sciences
St. Jude Children's Research Hospital
262 Danny Thomas Place 
Mail Stop 150
Memphis, TN 38105-3678
Phone: (90) 595-5767
FAX: (901) 595-3111
Email: James.hoffman@stjude.org
www.stjude.org/hoffman